Nuveen Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $2.74M | Sell |
49,643
-132,385
| -73% | -$7.32M | ﹤0.01% | 2251 |
|
|
2024
Q3 | $10.9M | Sell |
182,028
-137,114
| -43% | -$8.18M | ﹤0.01% | 1551 |
|
|
2024
Q2 | $20.3M | Buy |
319,142
+72,986
| +30% | +$4.65M | 0.01% | 1122 |
|
|
2024
Q1 | $17M | Buy |
246,156
+86,862
| +55% | +$6M | 0.01% | 1274 |
|
|
2023
Q4 | $8.78M | Sell |
159,294
-62,137
| -28% | -$3.43M | ﹤0.01% | 1672 |
|
|
2023
Q3 | $12.9M | Buy |
221,431
+180,491
| +441% | +$10.5M | ﹤0.01% | 1325 |
|
|
2023
Q2 | $2.2M | Hold |
40,940
| – | – | ﹤0.01% | 2292 |
|
|
2023
Q1 | $1.63M | Sell |
40,940
-3,977
| -9% | -$158K | ﹤0.01% | 2423 |
|
|
2022
Q4 | $1.81M | Sell |
44,917
-6,115
| -12% | -$246K | ﹤0.01% | 2433 |
|
|
2022
Q3 | $1.64M | Sell |
51,032
-602
| -1% | -$19.3K | ﹤0.01% | 2501 |
|
|
2022
Q2 | $1.53M | Buy |
51,634
+12,560
| +32% | +$373K | ﹤0.01% | 2578 |
|
|
2022
Q1 | $1.05M | Buy |
39,074
+3,427
| +10% | +$92.3K | ﹤0.01% | 2803 |
|
|
2021
Q4 | $1.6M | Sell |
35,647
-3,167
| -8% | -$142K | ﹤0.01% | 2675 |
|
|
2021
Q3 | $1.12M | Sell |
38,814
-2,200
| -5% | -$63.5K | ﹤0.01% | 2955 |
|
|
2021
Q2 | $1.44M | Sell |
41,014
-5,176
| -11% | -$181K | ﹤0.01% | 2859 |
|
|
2021
Q1 | $1.67M | Buy |
46,190
+3,922
| +9% | +$142K | ﹤0.01% | 2698 |
|
|
2020
Q4 | $1.23M | Buy |
42,268
+3,841
| +10% | +$112K | ﹤0.01% | 2732 |
|
|
2020
Q3 | $1.08M | Buy |
38,427
+137
| +0.4% | +$3.87K | ﹤0.01% | 2650 |
|
|
2020
Q2 | $1.24M | Sell |
38,290
-20,556
| -35% | -$665K | ﹤0.01% | 2527 |
|
|
2020
Q1 | $2.4M | Sell |
58,846
-3,017
| -5% | -$123K | ﹤0.01% | 2102 |
|
|
2019
Q4 | $3.82M | Sell |
61,863
-5,056
| -8% | -$312K | ﹤0.01% | 2128 |
|
|
2019
Q3 | $4.88M | Sell |
66,919
-19,100
| -22% | -$1.39M | ﹤0.01% | 1967 |
|
|
2019
Q2 | $7.07M | Buy |
+86,019
| New | +$7.07M | ﹤0.01% | 1802 |
|